Central Serous Chorioretinopathy (CSC) Unknown Status Phase 2 / 3 Trials for Bevacizumab (DB00112)

Also known as: Central Serous Chorioretinopathy / Central Serous Retinopathy (CSR) / Central Serous Retinopathy / Serous macular detachment / Chorioretinal disorder / Chorioretinopathy / Chorioretinal disorder NOS

IndicationStatusPhase
DBCOND0050251 (Central Serous Chorioretinopathy (CSC))Unknown Status2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00418431Intravitreal Bevacizumab for the Treatment of Central Serous ChorioretinopathyTreatment